FEATURED

Overdetecting Recurrence of Prostate Cancer

Prostate specific antigen screening in some cases led to overdetection of prostate cancer, and now the same is occurring with recurrence.

Diagnosis and Management of Castleman Disease

Castleman disease is a lesser seen lymphoproliferative disorder, with differing treatments.

Treatment of HPV-Associated Oropharynx Cancer

The ECOG conducted a trial to investigate whether deintensification was feasible in HPV-associated cancer.

NSAIDs for Prevention of Colon Cancer

NSAIDs target stem cells that have accumulated mutations that could lead to cancer development.

Post-Op Gastric Motility in Geriatrics

Many changes occur in the gastrointestinal tract during the aging process that can directly impact gastric motility following surgery.

Are Oncologists Working While Sick?

Research highlights how lack of guidelines regarding illness and adequate staffing at hospitals may link to presenteeism.

ARZERRA® (ofatumumab) for CLL

This slideshow reviews drug info for ARZERRA® (ofatumumab).

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

High Rates of Overdetection of Recurrence of Prostate Cancer

High Rates of Overdetection of Recurrence of Prostate Cancer

Prostate specific antigen (PSA) screening in some cases led to overdetection of prostate cancer, and now the same is occurring with recurrence.

Researchers Identify Mechanism by Which NSAIDs Prevent Colon Cancer

Researchers Identify Mechanism by Which NSAIDs Prevent Colon Cancer

NSAIDs target stem cells that have accumulated mutations that could lead to cancer development and a biochemical pathway that leads to apoptosis.

Feature Articles

Diagnosis and Management of Castleman Disease

Diagnosis and Management of Castleman Disease

[Cancer Control] Castleman disease is a lesser seen lymphoproliferative disorder, which is characterized as either localized or multicentric, with differing treatments typically utilized for each type.

Treatment Deintensification for HPV-Associated Oropharynx Cancer

Treatment Deintensification for HPV-Associated Oropharynx Cancer

The Eastern Cooperative Oncology Group (ECOG) conducted a trial to investigate whether treatment deintensification was feasible in patients with HPV-associated cancer.

Featured Videos

Fall Digital Issue

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs